PRELUDE THERAPEUTICS

Live / Registered — Registered (as of 06 Dec 2022)

What this means for you

Registered since 06 Dec 2022. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
88454877
Registration number
6918641
Mark type
Design + words
Filed
31 May 2019
Published for opposition
15 Mar 2022
Registered
06 Dec 2022
Attorney of record
Lisa Bollinger Gehman

Goods and services

  • Class 042 — Scientific and technological services: Research and development of drugs in the fields of oncology, hematology, autoimmune diseases, and rare diseases; scientific research for medical purposes in the fields of oncology, hematology, autoimmune diseases, and rare diseases; clinical research in the fields of oncology, hematology, autoimmune diseases, and rare diseases; scientific research and development of pharmaceuticals and biopharmaceuticals for the treatment of cancer, hematological diseases, autoimmune diseases, and rare diseases; providing websites featuring medical and scientific research information about pharmaceutical and biopharmaceutical drugs and their preparations; genetic testing for scientific research; genetic research in the fields of oncology, hematology, autoimmune diseases, and rare diseases; none of the foregoing in relation to or in the field of fertility

Owner

Prosecution history

  • 06 Dec 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 06 Dec 2022 — REGISTERED-PRINCIPAL REGISTER
  • 01 Nov 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 31 Oct 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 12 Oct 2022 — STATEMENT OF USE PROCESSING COMPLETE
  • 29 Sept 2022 — USE AMENDMENT FILED
  • 12 Oct 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 29 Sept 2022 — TEAS STATEMENT OF USE RECEIVED
  • 10 May 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 15 Mar 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 15 Mar 2022 — PUBLISHED FOR OPPOSITION
  • 23 Feb 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 06 Feb 2022 — ASSIGNED TO LIE
  • 04 Feb 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 03 Feb 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED

View this trademark record on Marksy